Munafa Stock Market Course + Intraday & FNO calls 
ALLO announcements Allogene Therapeutics, Inc. announcements and dividends declared NASDAQ
Allogene Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Allogene Therapeutics, Inc. ALLO
Allogene Therapeutics, Inc. ALLO listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic SubstancesAnnouncements and dividends declared by Allogene Therapeutics, Inc. ALLO
Allogene Therapeutics (ALLO) Surges 8.4%: Is This an Indication of Further Gains?
Allogene Therapeutics ALLO shares rallied 8.4% in the last trading session to close at .41. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 1.2% loss over
Announcement as on 24 April 2023
Allogene Therapeutics Shares Cross Above 200 DMA
In trading on Tuesday, shares of Allogene Therapeutics Inc (Symbol: ALLO) crossed above their 200 day moving average of .70, changing hands as high as .74 per share. Allogene Therapeutics Inc shares are currently trading up about 3.9% on the day. T
Announcement as on 22 November 2022
Up 18% In A Month, Will Allogene Therapeutics Stock See Higher Levels?
The stock price of Allogene Therapeutics (NASDAQ: ALLO), a biotechnology company focused on T-cell therapies for solid tumors, has seen an 18% rise over the last month, white it’s down 38% YTD. The stock price over the recent weeks has been buoyed by th
Announcement as on 06 April 2022
Up 18% In A Month, Will Allogene Therapeutics Stock See Higher Levels?
The stock price of Allogene Therapeutics (NASDAQ: ALLO), a biotechnology company focused on T-cell therapies for solid tumors, has seen an 18% rise over the last month, white it’s down 38% YTD. The stock price over the recent weeks has been buoyed by th
Announcement as on 06 April 2022
: Allogene Therapeutics stock drops as much as 40% as FDA puts hold on cancer drug study
Allogene Therapeutics Inc. ALLO shares plunged in the extended session Thursday after the biotech drug developer said the Food and Drug Administration placed a hold on the company’s cancer drug clinical trials. Allogene shares, which had closed up 1.7% a
Announcement as on 07 October 2021
Announcements by Allogene Therapeutics, Inc. first page | Next page |
ALLO Allogene Therapeutics, Inc. current price & indicator signals
Recent prices of ALLO Allogene Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 08 Mon Dec 2025 | 1.45 | 1.39 to 1.46 | 1.4% | 0.7 times |
| 05 Fri Dec 2025 | 1.43 | 1.42 to 1.47 | -0.69% | 1.05 times |
| 04 Thu Dec 2025 | 1.44 | 1.41 to 1.51 | -5.26% | 0.67 times |
| 03 Wed Dec 2025 | 1.52 | 1.33 to 1.52 | 13.43% | 1.48 times |
| 02 Tue Dec 2025 | 1.34 | 1.30 to 1.38 | -2.19% | 0.96 times |
| 01 Mon Dec 2025 | 1.37 | 1.35 to 1.45 | -6.16% | 0.84 times |
| 28 Fri Nov 2025 | 1.46 | 1.41 to 1.49 | 2.82% | 0.61 times |
| 26 Wed Nov 2025 | 1.42 | 1.31 to 1.43 | 4.41% | 1.07 times |
| 25 Tue Nov 2025 | 1.36 | 1.30 to 1.40 | 0.74% | 1.08 times |
| 24 Mon Nov 2025 | 1.35 | 1.21 to 1.35 | 9.76% | 1.55 times |
| 21 Fri Nov 2025 | 1.23 | 1.20 to 1.25 | -0.81% | 0.69 times |
| 20 Thu Nov 2025 | 1.24 | 1.22 to 1.33 | -1.59% | 1.13 times |
Videos related to: ALLO announcements Allogene Therapeutics, Inc. announcements and dividends declared NASDAQ
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
